Skip to main content
Nature Communications logoLink to Nature Communications
. 2020 Sep 17;11:4793. doi: 10.1038/s41467-020-18720-1

Author Correction: A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics

Michael A Crone 1,2,3, Miles Priestman 1,2, Marta Ciechonska 1,2, Kirsten Jensen 1,2,3, David J Sharp 3,4, Arthi Anand 5,6, Paul Randell 7,8, Marko Storch 1,2, Paul S Freemont 1,2,3,
PMCID: PMC7498595  PMID: 32943631

Correction to: Nature Communications 10.1038/s41467-020-18130-3, published online 08 September 2020.

The original version of this manuscript did not include a link to the RNA Extraction Procotol scripts that are publically available at Zenodo. The scripts can be found at the following URL: 10.5281/zenodo.4021454

In addition, the original version of this Article omitted a declaration from the Competing Interests statement, which should have included the following: “M. Priestman and M. Ciechonska are co-founders of Salient Labs. All other authors declare no competing interests.”

This has now been corrected in both the PDF and HTML versions of the Article.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES